Dedicated To Our Mission

Scientific Advisory Board

Jean-Philippe Pignol MSc, MD, PhD, FRCPC - Chair

Jean-Philippe Pignol MSc, MD, PhD, FRCPC - Chair

Dr. Pignol is Professor and Chairman of the Department of Radiation Oncology at the Erasmus MC Cancer Institute, Rotterdam, Netherlands. Dr. Pignol previously worked at the University of Toronto, Canada where he was a Professor in the Department of Radiation-Oncology and in the Department of Medical Biophysics. He holds a Ph.D. in nuclear physics. His career includes 20 years of clinical practice during which he has treated over 5,000 breast cancer cases. He is the innovator of Breast Microseed Treatment and is an investigator of several Permanent Breast Seed Implant (PBSI) studies. He has authored and/or co-authored over 100 peer-reviewed publications.

Juanita Crook, MD, FRCPC - Member

JuanitaCrook, MD, FRCPC - Member

Dr. Crook is a Professor of Radiation Oncology at the University of British Columbia and on staff at the Cancer Centre for the Southern Interior in Kelowna, B.C. She is a recognized expert in the field of brachytherapy for prostate cancer and penile cancer. Her research has included predictive factors for post implant toxicity, guidelines for the reporting of critical organ doses following brachytherapy and she has led the way in the use of MRI-CT fusion for quality assurance of prostate brachytherapy. She has written 23 book chapters, over 150 journal articles and is a frequent speaker at international meetings, in English, French and Spanish. She was Scientific Chair of the 2007 American Brachytherapy Society (ABS) meeting, regularly teaches at the ABS Prostate Brachytherapy School and is past president and chairman of the Board of the ABS. 

Diana Buist, PhD, MPH - Member

DianaBuist, PhD, MPH - Member

Diana S. M. Buist, PhD, MPH, is the Director of Research and Strategic Partnerships at the Group Health Research Institute (GHRI). She also works as a senior investigator specializing in epidemiology and health services research pursuing funded scientific research. Dr. Buist has been a key leader of two large national research consortia focused on improving cancer screening and outcomes. She has a strong record of practical research that has led to many efforts to improve care, including the development and refinement of national breast cancer screening guidelines. She is an affiliate professor in the Departments of Epidemiology and Health Services at the University of Washington School of Public Health and affiliate member at Fred Hutchinson Cancer Research Center.

Sandra Rorem - Member, Board Representative

SandraRorem - Member, Board Representative

Sandra’s accomplished career spans over 35 years of executive leadership in all facets of healthcare delivery and health-related companies, including leading five start-up and early-stage ventures.

Sandra served as a Hospital Administrator at Providence Health System’s Cherry Hill Campus in Seattle for 18 years, followed by five years as Chief Executive Officer for Medalia Healthcare -- a 350 physician group, formed by the merger of the Providence and Franciscan Health Systems primary care networks.

Following her tenure with the Providence Health System, Sandra shifted her focus to new ventures -- primarily start-up and early stage, health-related companies. Over the last 16 years she has led five.

Sandra has served on numerous boards, is a Board Certified member and Diplomat in the American College of Health Care Executives and a member of the American College of Medical Practice Administrators. She holds an MBA from the University of Washington Foster School Of Business.

Concure Oncology®

Dedicated to helping you put cancer behind you so you can get back to your life faster, with the peace of mind that comes from following the appropriate breast cancer treatment to help prevent a recurrence.

Kevin Kelley
Chief Executive Officer


Learn More | Meet the Team

Contact Us

Concure Oncology
3010 77th Ave. SE, Suite 206
Mercer Island, WA 98040